Related Interviews

Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha

Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola

A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju

Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit

The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj

CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven

Building a Portfolio with Multiple Levels of Diversification
January 04, 2019
Cuggino, Michael J.

Focusing on Health Care Through Venture Capital and a Crossover Fund
November 16, 2018
Gadicke, Dr. Ansbert

Buying Growing Small-Cap Companies at Attractive Valuations
November 02, 2018
McDowell, Thomas W., Thome, Cara M.

Clinical Trial Readouts on the Horizon for NASH Monotherapies
October 05, 2018
Seedhouse, Steven

A Favorable Future for Today’s Leaner, More Data-Driven Biotechs
October 02, 2018
Selvaraju, Raghuram

Seeing Growth in Smaller Med Tech Companies
July 13, 2018
Marckx, Brian

Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit

Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola

Biotech and Pharma Companies Set For Milestones in 2018
March 08, 2018
Nash, Edward

Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj

Weighting Health Care Subsectors According to Trends and Politics
August 29, 2017
Hearle, Michael J.

Looking for Rock-Solid, Dividend-Paying Companies
May 05, 2017
Woodley, Donald F.

Biotech Space on the Cusp of Seismic Changes
April 21, 2017
Chattopadhyay, Debjit

Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj

A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Shrader, Thomas

Small-to-Midcap Biotech Companies Expected to Regain Levels
March 10, 2017
Vlemmix, Michael

Assessing Each Client’s Unique Needs and Situation
March 10, 2017
Johnston, Todd A.

Building Portfolios with Dividend Growth and Diversification
March 10, 2017
Katz, David A.

Value Investing with a Business-Owner Mentality
February 10, 2017
Heinlein, John

Looking for Change in the Large-Cap Universe
December 30, 2016
Crawford, Kenneth, James, Meghan

Focusing on the Power of Compounding
November 04, 2016
Auxier, J. Jeffrey

Customized Portfolio Management Based on Value and Growth at a Reasonable Price
September 23, 2016
Roberts, Mark

Looking for Clean Balance Sheets and Cash Generation
September 23, 2016
Getsos, Jerry P.

Managing an Income-Based Portfolio with Price-Appreciation Features
September 23, 2016
Montoya, Christopher N.

Expanding the Range of Opportunities with a Multicap Approach
March 28, 2016
Sudyka Jr., Thomas J., Clauser, Chad C.

Emphasizing Caution and Capital Preservation in a Slow Growth Environment
March 11, 2016
Stark, George

High Investor Expectations for the Biotech Sector
January 15, 2016
Nash, Edward

Looking for the World’s Best Companies with the Best Balance Sheets
November 06, 2015
Edgerton, Bobby

Using a Thematic Approach to Growth Investing
October 23, 2015
Kenneth D. Malamed

Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015

Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014

Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014

Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014

Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014

Biotech Space Concentrates on Gene Therapy, CAR T-Cell Technology Side
July 23, 2014

Exercising Discipline with a Value Investing Philosophy
July 22, 2014

Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014

Finding Attractive Yields in Financials, IT and Health Care
March 27, 2014

A Balanced Yet Flexible Approach to Investing as the U.S. Economy Improves
February 24, 2014

Investing in Durable Secular Growth Themes
February 14, 2014

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013

New Product Generation and an Easing Regulatory Environment in Biopharmaceuticals
August 05, 2013

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013

Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013

Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013

Upside Exposure Through Convertibles While Reducing Downside
December 05, 2012

Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012

U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012

Innovation In Cardiovascular And Hepatic Devices And Drugs - Duane Nash - Wedbush Securities
November 21, 2011

Capitalizing On The Secular Increase Of Time Spent Online - Herman Leung - Susquehanna Financial Group Lllp
October 17, 2011

Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011

Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011

Technology Enablers Monetize Platform Shifts - Kerry Rice - Wedbush Securities
April 04, 2011

Investing In Large-cap, Dividend-growing Companies - Richard E. Helm - Cohen & Steers, Inc.
March 21, 2011

Options Trading & Volatility Management - Richard L. Selvala Jr. - Harvest Volatility Management
December 06, 2010

An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010

Static Or Expanding Hospital Margins Despite Soft Volumes - Frank G. Morgan - Rbc Capital Markets
September 20, 2010

Risk Factors & Overheated Insurance Valuations - Peter Newell - Vontobel Asset Management, Inc.
May 17, 2010

A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010

Investing In Gold & Precious Minerals - Frank E. Holmes - U.s. Global Investors, Inc.
February 08, 2010

Investing In Industrial Products & Services - Alexander J. Roepers - Atlantic Investment Management, Inc.
November 23, 2009

Investing In Commodities & Resources - James J. Puplava - Puplava Financial Services, Inc
November 02, 2009

Exceptional Opportunities In The Current Market - W. Mark Motley - Foster & Motley, Inc.
October 05, 2009

A Modern Approach To Graham & Dodd Investing - Thomas P. Au - R.w. Wentworth & Co., Inc.
October 05, 2009

Outlook For Commercial Airlines - Raymond Neidl - Calyon Securites (usa), Inc.
March 09, 2009

INVESTING IN LARGE & SMALL CAP GROWTH STOCKS - DEGAS A. WRIGHT - DECATUR CAPITAL MANAGEMENT, INC.
January 05, 2009

INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008

SMALL & MICRO-CAP BIOTECHNOLOGY COMPANIES - GEORGE B. ZAVOICO - CANTOR FITZGERALD
February 25, 2008

INVESTING IN LEISURE COMPANIES - STEVEN M. WIECZYNSKI - STIFEL, NICOLAUS & COMPANY, INC.
November 26, 2007

INVESTING IN HIGH QUALITY SMALL CAP COMPANIES - STEVEN R. PURVIS - LUTHER KING CAPITAL MANAGEMENT
July 16, 2007

INVESTING IN MID-CAP STOCKS - DAVID YUCIUS JR. - AURORA INVESTMENT COUNSEL
April 16, 2007

OUTLOOK FOR NATURAL GAS E&P COMPANIES - RICHARD MOORMAN - CAPITAL ONE SOUTHCOAST, INC.
January 15, 2007

CORE GROWTH INVESTING - KEITH C. GODDARD & CHANNING S. SMITH - CAPITAL ADVISORS, INC.
December 11, 2006

DIGITAL MARKETING TECHNOLOGY PROVIDERS - KYLE EVANS - STEPHENS INC.
November 06, 2006

RICHARD ASTER JR. - ASTER INVESTMENT MANAGEMENT
September 04, 2006

ROBIN ROBERTS - FIERY PHOENIX CONSULTING INC
July 10, 2006

ROUNDTABLE FORUM: GAMING
July 10, 2006

ROUNDTABLE FORUM: PRECIOUS METALS
June 26, 2006

Stacey Renner - Ch Energy Group Inc (chg)
May 05, 2006

PACKAGED FOODS & AGRIBUSINESS: JOHN MCMILLIN - PRUDENTIAL EQUITY GROUP LLC
February 27, 2006

STEPHEN PATTEN - SECTORAL ASSET MANAGEMENT INC
February 27, 2006

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

AGRIBUSINESS & PACKAGED FOOD COMPANIES: CHRISTINE MCCRACKEN - FTN MIDWEST SECURITIES CORP
November 14, 2005

R.BRIDGES / J.HUBER - GENEVA INVESTMENT MANAGEMENT OF CHICAGO LLC
August 08, 2005

K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005

ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005

LEE DELAPORTE - DREMAN VALUE MANAGEMENT LLC
June 06, 2005

Oscar Spieler - Frontline Ltd (fro)
March 07, 2005

OUTLOOK FOR PAPER & FOREST PRODUCTS: STEVE CHERCOVER - D.A.DAVIDSON & CO
September 20, 2004

SPECIALTY PHARMACEUTICALS & DRUG DELIVERY: LOUIS WEBB - WR HAMBRECHT & CO
September 06, 2004

FREIGHT FORWARDERS & INTEGRATED CARRIERS: MARK DAVIS - FTN MIDWEST RESEARCH SECURITIES CORP
July 12, 2004

BARBARA MARCIN - GABELLI ASSET MANAGEMENT INC
June 07, 2004

DATA STORAGE & SERVICES: DANIEL RENOUARD - ROBERT W. BAIRD & CO
March 08, 2004

JOHN FRIEDRICHSEN - FIRSTSERVICE CORPORATION (FSRV)
February 23, 2004

NANCY HOLLAND - ABN AMRO ASSET MANAGEMENT (USA) LLC
February 23, 2004

J.andrew Richey - Icc Capital Management
October 27, 2003

J.mcalear / D.snee - Columbia Management Group
September 22, 2003

P.morris / S.teach - National Rural Electric Cooperative Association
September 01, 2003

L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003

Small Cap Biotechnology Companies: Russell Gilbertson - Roth Capital Partners Llc
July 28, 2003

Investing In Biotechnology: Mark Monane - Needham & Co
June 02, 2003

Christian Bertelsen - Phoenix Investment Partners / Duff & Phelps
April 28, 2003

Peter Ganucheau Iv - Gsb Investment Management Inc
April 28, 2003

Outlook For Semiconductor Stocks: Danial Scovel - Needham & Co
April 28, 2003

Richard Parry - Tom Johnson Investment Management Inc
April 14, 2003

Michael Mullarkey - Workstream Inc (wstm)
November 25, 2002

U.s. Pharmaceutical Companies: J.riccardo/s.shevick - Bear, Stearns & Co
September 13, 2002

Mark Davidson - Fiduciary Services Corporation
July 08, 2002

Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002

Catherine Mcleod-seltzer - Pacific Rim Mining (pmu)
May 27, 2002

Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002

Alexander Muromcew - Loomis, Sayles & Co
May 06, 2002

Jon Hickman - Jurika & Voyles
April 01, 2002

Merchant Power Companies & Utilities: Thomas Hamlin - Wachovia Securities
October 29, 2001

European Biotechnology Companies: Karl Keegan - Ubs Warburg
October 12, 2001

Anthony Maramarco - David L. Babson & Company
October 01, 2001

Mary Ann Gray - Federated Kaufmann Fund
June 07, 2001

Lissa Morgenthaler - Monterey Murphy New World Biotechnology Fund
June 07, 2001

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001

Roundtable Forum: Investing In Gold Companies
December 25, 2000

Outlook For Biotechnology Stocks: William Slattery - Deerfield Management
December 18, 2000

Chuck Watson - Dynegy Inc (dyn)
September 20, 2000

John Windeler - Alliance & Leicester Plc (al.l)
September 11, 2000

Todd Chuckry - Request Seismic Surveys Ltd (rsh.to)
August 21, 2000

Allen Ashcroft Jr. - Allied Investment Advisors
June 05, 2000

H. Giles Knight - Ark Funds
February 14, 2000

Pharmaceutical Services : Ken Miller - Chase H&q
January 13, 2000

Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000

Roundtable Forum: Communications Equipment
January 10, 2000

Roundtable Forum: Major Chemicals
December 20, 1999

David N. Richardson - Asset Management Corporation
November 08, 1999

Wireless Equipment : Brian Modoff - Deutsche Banc Alex. Brown
November 04, 1999

Outlook For Biotechnology : Peter F. Drake - Prudential Securities
November 01, 1999

Anthony M. Marlon - Sierra Health Services Inc (sie)
December 14, 1998

Practice Management: Veterinary & Dental : Anne Reese - Loewenbaum &co
October 05, 1998

Roundtable Forum: Computer Telephony Integration
April 13, 1998